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ABSTRACT 
Aim 
To compare occupational flying hours (a 
surrogate for occupational exposure to 
radiation) of commercial pilots subsequently 
diagnosed with melanoma, with those without 
melanoma. 
 
Methods 
Nested case-control study of de-identified male 
commercial pilots in Australia 2011- 
 
2016, ascertained through the Civil Aviation 
Safety Authority (CASA). Cases were pilots 
diagnosed with melanoma 2011-2016; controls 
were randomly-selected pilots age-matched 
1:2 with invasive cases. Total flying hours and 
hours flown in the last 6 months in 2011, date 
of birth and state of residence were also 
obtained. We estimated the association 
between total flying hours (in tertile groups), 
and melanoma by odds ratios adjusted for age 
and state (ORsadj; 95% confidence intervals 
(CIs)). 
 
Results 
During 2011- 2016, 51 pilots developed 
invasive melanoma and 63, in situ (mean ages 
47 and 49 years, respectively). Their median 
cumulative flying hours in 2011 were 6,108 and 
6,900 respectively, compared with 7,500 for 
102 control pilots (mean age 48.6). Risk of 
invasive melanoma did not increase per 1000 
total hours flown (ORadj=1.00) nor did risk 
increase in pilots with highest vs lowest total 
flying hours (ORadj=1.18, 95% CI 0.44-3.15). 
Total flying hours were inversely associated 
with invasive melanoma development in pilots 
aged < 50 (ORadj=0.37, not significant), and not 
associated with melanoma on exposed sites. 
Recent flying hours were not associated with 
melanoma. Results were unchanged with 
inclusion of in situ cases. 
 
Conclusion 
Risk of melanoma in Australian commercial 
pilots is unrelated to cumulative or recent 
occupational exposure to radiation as indicated 
by total and recent flying hours. 
 
INTRODUCTION 
Historically, melanoma has been regarded as a 
health problem that is overrepresented in airline 
pilots compared with the general population. Two 
recent systematic reviews of all published studies 
on this topic showed that the incidence is raised 
around 2-fold in pilots compared with the general 
population1,2. Even more concerning were the 
systematic review findings that melanoma 
 mortality rates in pilots were also significantly 
double the rates expected in people in the general 
population of the same age and sex1. The main 
proposed mechanism underlying these raised 
melanoma risks among pilots has been high 
ultraviolet (UV) radiation exposure outside the 
work environment1-4, namely through ambient 
and recreational sun exposure, but occupational 
exposures to cosmic (ionizing) radiation and to 
UVA radiation remain as possible contributors2.  
 
Inspection of the published studies that have 
reported pilots’ increased melanoma risk and 
increased mortality reveals them to be largely out-
of-date. Virtually all studies that have been pooled 
were conducted last century1, and some showing 
high melanoma risk estimates, concerned pilots 
who were flying aircraft in the 1960s and 1970s3, 5, 
6 and even earlier in the 1940s7. Moreover, all 
studies summarised in the systematic reviews to 
date were conducted in northern Europe and 
North America1. Consequently, the relevance of 
the findings of raised melanoma risk from these 
systematic reviews to modern-day Australian 
airline pilots is questionable.  
 
In order to address the issues of currency and 
local relevance, we recently conducted a study of 
the incidence of cutaneous melanoma in 
Australian commercial pilots compared with the 
general population8. We used de-identified data 
from the Australian Civil Aviation Safety Authority 
(CASA) for commercial pilots who had a 
histologically diagnosed melanoma in the period 
2011-2016, and estimated age-specific incidence 
rates. When we compared these with 
corresponding population rates, we found no 
significant increase in the incidence rate of 
invasive melanoma, and a modestly raised (by 
around 40%) incidence rate of in situ melanoma8. 
We interpreted the elevated recorded rates of in 
situ melanoma as reflecting the more frequent (at 
least annual) medical surveillance that pilots 
undergo compared with the general population.  
 
A major weakness of this study of Australian-
licensed commercial pilots was the lack of any 
data regarding level of occupational exposure to 
radiation, either cosmic or UV. Indeed this has 
been a weakness of many studies of melanoma 
risk among airline pilots to date. With regard to 
ionising radiation, while there are no national 
occupational exposure data available for pilots in 
Australia, large airlines perform detailed modelling 
of the ionising radiation exposure of their aircrews 
according to their flight paths and flying hours. This 
suggests that a substantial proportion of 
Australian pilots are being monitored in this way 
and are not exceeding annual doses of 6 mSv, the 
annual reference level recommended by the 
Australian Radiation Protection and Nuclear 
Safety Agency9 or the 5-year dose limit of 100 
mSv. However, while medium-term occupational 
limits are not exceeded, commercial pilots may be 
exposed to ionising radiation over lengthy careers 
of several decades and some pilots (e.g. those 
flying long haul regularly), may receive high 
cumulative doses of ionising radiation over their 
lifetimes. Similarly, concerning UV exposure, it is 
known that levels of UVB are low to negligible on 
the flight deck of modern airlines, but UVA levels 
may be higher2. 
 
 
AIM 
 
We set out to address these gaps in evidence 
indirectly, by comparing the number of flying 
hours, both lifetime total, and subtotal in the 
previous 6 months, of pilots who subsequently 
developed cutaneous melanoma, with the flying 
hours of a group of pilots who did not develop 
melanoma. We hypothesised firstly that if 
occupational radiation (cosmic and/or UV) played 
a causal role, pilots with the highest total flying 
hours would be at increased risk of developing 
invasive melanoma compared with those with the 
lowest number of cumulative hours, and there 
would be a dose-response association. Given the 
strong correlation of age and total flying hours, we 
further hypothesised that any causal positive 
association would be stronger in younger pilots 
(<50 years) than in older pilots. Also if 
occupational UV radiation were causal as 
opposed to occupational cosmic radiation, we 
hypothesised that risk of invasive melanoma of 
exposed sites (head and neck, upper limbs 
combined) would be increased substantially 
among those with the highest total flying hours 
compared with those with the lowest totals. Finally, 
we speculated that if UV radiation in the last 6 
months before the 2011 baseline played a 
promotional role in melanoma development, we 
would see an increased risk of invasive melanoma 
diagnosed in 2011-2012 among those with the 
highest compared with the lowest flying hours in 
the last 6 months. Additionally we assessed the 
corresponding risks of all melanoma (invasive and 
in situ) in the above scenarios, but this was not the 
primary outcome because of the likely influence of 
detection bias on risk of in situ disease. 
 
 
METHODS 
Study Population 
We conducted a case-control study nested within 
a cohort of male commercial pilots in Australia 
(there were too few female pilots for meaningful 
analysis, and so they were excluded a priori). The 
 cohort and data source have been described in 
detail previously8. Briefly, we ascertained the de-
identified study population through the electronic 
Medical Record System (MRS) of CASA. CASA 
issues a range of licenses for the conduct of 
aviation in Australia, and it holds data gathered 
from routine medical examinations of flight crew 
licensees. Three different classes of medical 
certificates are issued to applicants who meet 
relevant medical standards, and commercial 
pilots, among others, are holders of class 1 
medical certificates8.  
For this study, we analysed the data of all pilots 
with a valid class 1 licence at any time during the 
period January 2011 to December 2016. Class 1 
medical certificates are valid for one year, except 
for pilots aged 60 years or older for who medical 
examination is required every 6 months. Ethical 
approval was obtained from the Human Research 
Ethics Committee of the QIMR Berghofer Medical 
Research Institute. We ascertained those pilots 
diagnosed with invasive or in situ melanoma in this 
period, and matched male pilots with invasive 
melanoma, in a ratio of 1:2, with male pilots of the 
same ages, randomly selected form all pilots who 
held a valid class 1 medical certificate in 2011 and 
had no melanoma history to the end of 2018. We 
confirmed details about cases’ melanomas 
including date of diagnosis, anatomical site, and 
invasiveness by manual review of histopathology 
reports. 
Total cumulative flying hours (including any 
previous military flying) and hours flown during the 
last 6 months in relation to pilots’ 2011 application 
were also obtained through the CASA MRS, as 
well as date of birth and current state of residence. 
 
Statistical Analyses 
We calculated median number of flying hours 
(inter-quartile range, IQR) at baseline in 2011 for 
cases and controls, and for dose-response 
assessment, categorised flying hours by tertile 
groups based on the distribution of flying hours 
among control pilots. Using logistic regression 
analyses, we calculated the crude and adjusted 
odds ratios (OR) ad 95% confidence intervals (Cis) 
to estimate the association between flying hours 
and melanoma  development, adjusting for age 
and state of residence as potential confounders. 
We also modelled flying hours as a linear term and 
calculated risk of melanoma per 100-hour 
increments of total flying hours. The primary 
outcome was invasive melanoma, and we 
performed sensitivity analyses by repeating the 
above analyses after the inclusion of cases with in 
situ melanoma. All statistical analyses were 
carried out using SAS 9.4 software (SAS Institute, 
Cary, NC). 
 
RESULTS 
Between 2011 and 2016, 51 pilots developed 
invasive melanoma (69% held an Airline Transport 
Pilot Licence (ATPL); 29% a Commercial Pilot 
Licence (CPL); 2% an ‘other/unspecified’ licence 
type), and 63 developed in situ melanoma (67% 
ATPL; 30% CPL; 3% ‘other/unspecified’). For 
each invasive case, 2 controls were selected, 
giving 102 controls (licence types not available) 
included in the analysis. There was no difference 
in broad age groups between invasive cases and 
controls (Table 1) or their mean ages (47 vs. 48.6 
years respectively, p=0.37) reflecting the 
matching, though more pilots with in situ than 
invasive melanoma were aged over 50 years. The 
majority of pilots with melanoma lived in 
Queensland (40%), followed by New South Wales 
(24%), while the majority of pilots in the control 
group lived in New South Wales (32%) followed by 
Queensland (28%) (Table 1). Median cumulative 
flying hours at baseline (2011) were 6,108 for 
pilots with invasive melanoma; 6,900 for pilots with 
any melanoma (invasive or in situ); and 7,500 for 
control pilots, all with similar IQRs (Table 1). 
 
 
 
 
Table 1. Baseline characteristics of male pilots 
included in the study 
 
Characteristics Invasive 
cases 
only 
(n=51) 
Invasive 
+ in situ 
cases 
(n=114) 
Controls 
(n=102) 
Age (in years) 
at diagnosis, 
mean (SD) 
47 (10.1) 49 (11.3) 48.6 
(11.3) 
Age group, n 
(%) 
   
<50 30 (59) 57 (50) 60 (59) 
50+ 21 (41) 57 (50) 42 (41) 
State of 
residence, n 
(%) 
   
QLD 19 (37) 45 (40) 29 (28) 
NSW 12 (24) 27 (24) 33 (32) 
VIC 10 (20) 20 (18) 15 (15) 
Other States 10 (20) 22 (19) 25 (25) 
Total flying 
hours, median 
(IQR) 
6108 
(1900-
14200) 
6900 
(2215-
15060) 
7500 
(2725-
14150) 
Hours flown in 
last 6 months, 
median (IQR) 
200 (54-
350) 
200 (70-
328) 
206 (80-
323) 
 
 Estimated risk of invasive melanoma per 1000 
total flying hours was 0.99 (crude) and 1.00 (95% 
CI: 0.94-1.04) after adjustment for age and state 
of residence. Pilots in the highest (median 16,490) 
vs lowest (median 1,680) tertile group for total 
flying hours had a slightly decreased crude risk of 
invasive melanoma (ORcrude=0.89) which rose 
slightly after adjustment (ORadj=1.18) but non-
significantly with very wide 95% CI (0.44- 3.15) 
(Table 2). Risk of invasive or in situ melanoma 
(combined) was neither increased on crude nor 
adjusted analysis (ORadj=0.85, 95% CI: 0.40-
1.79) when comparing those in the highest and 
lowest tertile groups of total flying hours (Table 2). 
 
Table 2. Association between flying hours and 
melanoma risk among class 1 male pilots 
 
Total flying hours Invasive 
cases only  
OR (95% CI) 
(n=51) 
Invasive + 
in situ 
cases OR 
(95% CI) 
(n=114) 
Crude analyses   
Total flying hours 
(per 1000hrs)1 
0.99 (0.94-
1.04) 
1.00 (0.96-
1.04) 
Total flying hours 
(Tertile groups 
[median, range])2 
  
T1 [1680 (5, 4500)] Reference Reference 
T2 [7500 (4800, 
12378)] 
0.94 (0.42-
2.13) 
0.88 (0.46-
1.69) 
T3 [16490 (12470, 
28000)] 
0.89 (0.39-
2.03) 
0.90 (0.47-
1.73) 
Adjusted 
analyses3 
  
Total flying hours 
(per 1000hrs)1 
1.00 (0.94-
1.06) 
1.00 (.95-
1.04) 
Total flying hours 
(Tertile groups) 
  
T1 Reference Reference 
T2 1.08 (0.45-
2.57) 
0.85 (0.43-
1.67) 
T3 1.18 (0.44-
3.15) 
0.85 (0.40-
1.79) 
 
 
1Total flying hours modelled as linear term per 1000 
hours increase 
2Tertile distribution are presented as [median (min, 
max)] 
3Models adjusted for age and state of residence 
 
 
 
 
When we restricted analyses to pilots aged <50 
years to minimize residual confounding by age, 
results were similarly null or negative. After 
adjustment for state of residence, there was a non-
significant 7% decrease in risk of invasive 
melanoma for every extra 1000 flying hours 
recorded, and a non-significant inverse 
association in the pilots aged < 50 years who were 
in the highest (median 12,985) vs lowest (median 
893) groups for total flying hours (ORadj=0.37, 
95% CI: 0.09-1.36) (Table 3). Including in situ 
melanoma made no difference to these results. 
 
Table 3. Association between flying hours and 
melanoma risk among class 1 male pilots ages 
less than 50 years at time of diagnosis 
 
Total flying hours Invasive 
cases only  
OR (95% CI) 
(n=30) 
Invasive + 
in situ 
cases OR 
(95% CI) 
(n=57) 
Total flying hours 
(per 1000hrs)1,2 
0.93 (0.84-
1.02) 
0.94 (0.86-
1.02) 
Total flying hours (Tertile groups [median, range])2,3 
T1 [893 (5, 3100)] Reference Reference 
T2 [5000 (3200, 
9800)] 
1.04 (0.38-
2.89) 
1.12 (0.46-
2.73) 
T3 [12985 (10060, 
20561)] 
0.37 (0.09-
1.36) 
0.42 (0.14-
1.28) 
 
 
1Total flying hours modelled as linear term per 1000 
hours increase 
2Models adjusted for age and state of residence 
3Tertile distributions are presented as [median (min, 
max)] 
 
We next examined risk of melanoma specifically of 
the head and neck and upper limbs in relation to 
total flying hours, and again found no increase in 
invasive melanoma on these exposed sites in 
pilots with the highest vs lowest flying hours 
(ORadj=0.99, 95% CI: 0.20-4.91) or in risk of 
invasive and in situ melanoma combined (Table 
4). 
  
  
Table 4. Association between flying hours and 
melanoma risk among class 1 male pilots 
diagnosed with melanoma on head and neck and 
upper limbs 
 
Total flying hours Head & Neck & Upper Limb 
 Invasive 
cases only  
OR (95% CI) 
(n=13) 
Invasive + 
in situ 
cases OR 
(95% CI) 
(n=38) 
Total flying hours 
(per 1000hrs)1,2 
1.01 (0.91-
1.11) 
0.99 (0.93-
1.05) 
Total flying hours (Tertile groups)2 
T1 Reference Reference 
T2 0.61 (0.13-
2.83) 
0.85 (0.33-
2.18) 
T3 0.99 (0.20-
4.91) 
0.81 (0.29-
2.20) 
1Total flying hours modelled as linear term per 1000 
hours increase 
2Models adjusted for age and state of residence 
 
Finally, when we assessed associations between 
number of hours flown in the 6 months before 2011 
baseline, and invasive melanoma diagnosed in 
2011-2012, we found that they also tended to be 
inverse after adjusting for age, state and total 
flying hours. There was a non-significant 15% 
decrease in invasive melanoma risk for every 50-
hour increment in recent flying hours (ORadj= 
0.85, 95% CI: 0.68-1.05) and a non-significant 
60% decrease in those with the highest (median 
350) vs lowest (median 48) number of hours flown 
in the previous 6 months (ORadj=0.39, 95% CI: 
0.09-1.69) (Table 5). There was no substantive 
difference when pilots with in situ melanoma were 
included. 
 
Table 5. Association between flying hours and 
melanoma risk among class 1 male pilots 
diagnosed with melanoma in 2011-2012 
 
Total flying hours Year of Diagnosis 2011-
2012 
 Invasive 
cases only  
OR (95% CI) 
(n=22) 
Invasive + 
in situ 
cases OR 
(95% CI) 
(n=45) 
Hours flown in last 6 
months (per 
50hrs)1,2 
0.85 (0.68-
1.05) 
0.98 (0.85-
1.13) 
Hours flown in last 6 months  
(Tertile groups [Tertile groups])2,3 
T1 [0.48 (0, 114)] Reference Reference 
T2 [200 (120, 270)] 0.45 (0.11-
1.86) 
0.76 (0.26-
2.24) 
T3 [350 (300-690)] 0.39 (0.09-
1.69) 
0.66 (0.22-
2.05) 
1Hours flown in last 6 months modelled as linear term 
per 50 hours increase 
2Models adjusted for age, state of residence and total 
flying hours 
3Tertile distributions are presented as [median (min, 
max)] 
 
 
DISCUSSION 
In this study we tested the hypothesis that high 
exposure to occupational radiation increases the 
risk of invasive melanoma in Australian 
commercial pilots, by using total flying hours as a 
surrogate indicator of accumulated level of 
exposure. We found no association between total 
flying hours and development of invasive 
melanoma overall, and also no increase in risk 
when we limited the analysis to pilots younger than 
50 years to reduce confounding by age. To further 
test the UV causal hypothesis, we estimated risk 
of melanoma only on anatomic sites potentially 
exposed to UV on the flight deck (head, neck and 
upper limbs combined) in relation to total flying 
hours, and results again showed no or inverse 
associations but results were very imprecise due 
to the small number of eligible cases. Finally, we 
evaluated the possible promotional role of recent 
occupational UV radiation in the development of 
melanoma in pilots, by examining the risk of 
invasive melanoma in 2011-2012 in those with the 
highest vs lowest number of hours flown in the 
previous 6 months. Again, there was a decrease 
in ORs for invasive melanoma after adjustment for 
other factors including total flying hours. 
Corresponding results of the above analyses were 
unchanged when we expanded the to include in 
situ melanoma. 
 
These findings are reassuring and are consistent 
with our previous study that showed no increase in 
melanoma incidence in commercial pilots 
compared with the general population8. The 
present results supplement the earlier descriptive 
evidence by including normative data for flying 
hours in pilots without melanoma, and then 
confirming a lack of dose-response relationship 
between increasing total flying hours among pilots 
(ranging from the lowest group median of 1,680 to 
highest group median of 16,490) and melanoma 
diagnosis. We recognize that total flying hours is 
an imperfect surrogate for accumulated 
occupational radiation exposure when this 
measure takes no account of variation with 
different cruising altitudes and routes flown, for 
example, the higher exposure to ionising radiation 
among pilots who regularly fly polar routes 
compared with lower latitude routes.  
 
However, we believe that these Australian data 
can distinguish the melanoma risk of pilots, 
especially the younger pilots, who have flown 
many long-haul routes, and thus these data 
 represent an advance on the amount and quality 
of evidence regarding dose-response for flying 
hours and melanoma in contemporary pilots. 
Some previous studies have also examined flying 
hours in relation to risk of melanoma, but there 
were limitations and mixed results. For instance, a 
study of Icelandic airline pilots was based on only 
5 cases of melanoma, and though they reported a 
strong association between flying hours and 
melanoma, they were unable to properly evaluate 
dose-response10. A Norwegian study reported a 
rise in melanoma incidence in pilots with 
increasing total flying hours, but these were pilots 
licensed between 1946 and 1994, a time, as the 
authors acknowledged, when long-range inter-
continental flights likely represented increased 
opportunity for leisure-time sunbathing7. A more 
recent UK study of cancer in pilots found that 
melanoma rates were increased not only in flight 
crew with increasing number of flying hours, but 
also in air traffic controllers with increasing number 
of radar hours, with no excess rates seen among 
the pilots compared with the air traffic controllers4. 
Furthermore, melanoma rates in both 
occupational groups were most strongly predicted 
by sun-sensitive skin and sunbathing to get a tan4. 
Our previous systematic review found that a few 
other studies had reported dose-response 
relationships between estimated exposure to UV 
or cosmic radiation and cancers of the skin 
(including melanoma) based on employment 
duration or flying hours, but the diversity of 
measures prevented any pooled estimation of 
dose-response1.  
 
Our study of pilots’ total cumulative flying hours as 
a de facto measure of long-term exposure to 
cosmic radiation adds to evidence that relies 
mostly on evaluation of annual doses of cosmic 
radiation11 or at most 5-year doses. This is 
because a measure of potential accumulated 
radiation dose over a pilot’s lifetime is likely to be 
far more pertinent to risk of occupational 
carcinogenesis in the long term. While the two 
above-mentioned Nordic studies7, 10 also modelled 
cumulative mSv doses in their pilots, small 
numbers of cases restricted their assessments of 
a possible association with melanoma. 
 
The relatively small number of pilots with invasive 
melanoma diagnosed in our study, also limited our 
own ability to explore detailed hypotheses in 
subgroups (eg by site or year of diagnosis of 
melanoma), even though our Australian series 
was considerably larger than most European 
series. Also we were unable to adjust for risk 
factors such as skin phenotype and recreational 
sun exposure, although confounding by the former 
is unlikely since flying hours should be unrelated 
to phenotype. We did adjust for state of residence, 
which controlled for ambient UV exposure 
(assuming stable state of residence for most 
pilots) and therefore recreational sun exposure to 
some degree, and as well, this controlled for the 
large differences in background melanoma 
incidence in Australia by state8. Our cases and 
controls included a mix of pilots with a class 1 
licence, with about two-thirds of the cases holding 
an ATPL8 and a presumed half of the controls 
(since half of all class 1 licence holders at that time 
held an ATPL8). There were 5 control pilots and 
one case pilot (with in situ melanoma) who 
reported zero flying hours in the previous 6 months 
in 2011, and the median recent flying hours in the 
tertile subgroup of controls with lowest flying hours 
in the previous 6 months was 48, indicating that 
most in our study were active commercial pilots. 
 
CONCLUSION 
Notwithstanding the various study limitations, 
these data add new evidence in favour of the null 
hypothesis, namely that the risks of invasive 
melanoma, and of invasive and in situ melanoma 
combined, do not increase in Australian pilots with 
increasing accumulated occupational exposure to 
radiation, cosmic and/ or UV, as measured by total 
flying hours. 
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